Nasal Vaccine Offers Superior, Long-Lasting COVID-19 Immunity
A new intranasal vaccine candidate developed shows improved and longer-lasting immunity against COVID-19, potentially reducing the need for booster shots by enhancing mucosal and systemic immune responses.Duke-NUS-led research reveals an intranasal vaccine candidate that offers superior, long-lasting COVID-19 immunity, potentially minimizing booster requirements.Novel findings from a preclinical head-to-head comparison show that administering a COVID-19 vaccine as a nasal spray, rather than subcutaneous injection,…